FLT3 and acute myeloid leukemia: However, the second-generation alkynyl aminoisoquinoline and alkynyl aminonaphthyridine compounds (Fig. 2) had reduced LogP values and possessed potent activity against AML cell lines harboring secondary FLT3 mutations (Fig. 4).